A Guide for the Interpretation and Reporting of Sequence Variants in Cancer

Recently we hosted a webinar in which Medical Director, Shalini Verma, and VP Product, Andy Bredemeyer, reviewed and applied the Association for Molecular Pathology (AMP) joint consensus guidelines for the interpretation and reporting of sequence variants in cancer. 

We received an overwhelming number of requests for the content so we decided to put the recommendations into different formats:

-Scannable infographic

-Printable document

Download the guide in either format now.